Related Experiment Video
Updated: Sep 10, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Vascular function in women with heart failure with preserved ejection fraction: a mismatch beyond diastole
Nicholas A Carlini1,2, D Walter Wray1,2,3, Kerrie L Moreau4,5
1Department of Internal Medicine, Division of Geriatrics, University of Utah, Salt Lake City, Utah, United States.
Insights
Heart failure with preserved ejection fraction (HFpEF) affects men and women differently, particularly in vascular health. Estrogen loss in women may worsen HFpEF outcomes, highlighting sex-specific health implications.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Women's Health
Background:
- Heart failure with preserved ejection fraction (HFpEF) accounts for approximately 50% of heart failure cases.
- HFpEF is more common in women, with distinct clinical presentations and prognoses compared to men.
- Sex differences in HFpEF may stem from anatomical, physiological, and hormonal variations, including the role of estrogen.
Purpose of the Study:
- To review current evidence on sex differences in vascular function within HFpEF.
- To explore the impact of estrogen loss on female HFpEF physiology.
- To identify potential future research directions for women's health in HFpEF.
Main Methods:
- Mini-review of recent scientific literature.
- Focus on coronary microvascular function, peripheral vascular function, and central arterial stiffness.
- Examination of hormonal mechanisms, particularly estrogen's role.
Main Results:
- Significant sex-based disparities exist in vascular health among HFpEF patients.
- Estrogen deficiency in women may negatively impact vascular parameters.
- Age-related hormonal changes contribute to distinct HFpEF phenotypes in women.
Conclusions:
- Sex differences, especially hormonal ones, are critical in understanding HFpEF.
- Estrogen's role warrants further investigation for targeted women's health interventions.
- Addressing sex-specific mechanisms is crucial for improving HFpEF management.
Abstract:
Heart failure with preserved ejection fraction (HFpEF) is a complex multiorgan clinical syndrome representing ∼50% of all heart failure-related cases nationwide. HFpEF is more prevalent in women, yet both men and women with HFpEF present with distinct clinical phenotypes and prognosis that may be attributable, in part, to sex differences in anatomical, physiological, and/or hormonal characteristics. Of particular interest is the role of sex hormones, namely, estrogen, as a contributing factor to sex differences in vascular health in patients with HFpEF. This mini review provides a summary of recent evidence regarding sex differences in coronary microvascular function, peripheral vascular function, and central arterial stiffness in patients with HFpEF. Focus will also be given to potential mechanisms by which age-related loss of estrogen may alter these aspects of physiology in women with HFpEF and provide potential future directions related to implications for women's health in adults with HFpEF.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Heart Failure Drugs: Diuretics
Heart Failure III: Clinical Manifestations

